These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 25956892)

  • 1. Reply to Solnick.
    Corey GR; Stryjewski ME
    Clin Infect Dis; 2015 Aug; 61(3):485-6. PubMed ID: 25956892
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to Solnick.
    Goldstein EJ; Saravolatz LD
    Clin Infect Dis; 2015 Aug; 61(3):484-5. PubMed ID: 25956894
    [No Abstract]   [Full Text] [Related]  

  • 3. Invited review articles: do they inform or do they advertise?
    Solnick JV
    Clin Infect Dis; 2015 Aug; 61(3):484. PubMed ID: 25956889
    [No Abstract]   [Full Text] [Related]  

  • 4. ASHP policy on the acceptance of advertising.
    Am J Hosp Pharm; 1992 Jan; 49(1):160-1. PubMed ID: 1442809
    [No Abstract]   [Full Text] [Related]  

  • 5. Advertising standards.
    Drug Ther Bull; 2013 Jul; 51(7):73. PubMed ID: 23842632
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmaceutical advertising.
    Haque S
    CMAJ; 2005 Oct; 173(9):1066; discussion 1066-7. PubMed ID: 16247105
    [No Abstract]   [Full Text] [Related]  

  • 7. Advertising and clinical investigation.
    Ciaglia P; Levy H; Ryan TF
    Chest; 1990 Nov; 98(5):1309-10. PubMed ID: 2225998
    [No Abstract]   [Full Text] [Related]  

  • 8. Traveling medicine shows: a modern update?
    Carroll-Johnson RM
    Oncol Nurs Forum; 1992 Oct; 19(9):1315. PubMed ID: 1437666
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence-based advertising?
    Replogle WH
    J Am Board Fam Pract; 2001; 14(5):399. PubMed ID: 11572549
    [No Abstract]   [Full Text] [Related]  

  • 10. Yes, industry influence is excessive.
    Shah AA; Finucane TE
    Int Psychogeriatr; 2007 Dec; 19(6):1004-10; discussion 1014-20. PubMed ID: 17711608
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug company-sponsored symposia: pros and cons.
    Finucane T
    Am J Med; 1987 Oct; 83(4):811-2. PubMed ID: 3674075
    [No Abstract]   [Full Text] [Related]  

  • 12. Trojan horse advertising.
    Friedman JH
    Med Health R I; 1999 May; 82(5):150. PubMed ID: 10343487
    [No Abstract]   [Full Text] [Related]  

  • 13. Publication ethics policies for medical journals.
    Pai SA
    Indian J Med Ethics; 2004; 1(3):93. PubMed ID: 16370089
    [No Abstract]   [Full Text] [Related]  

  • 14. College activities and the ethics of advertising.
    Ryan C; Walter G; Robertson M
    Australas Psychiatry; 2010 Apr; 18(2):101-5. PubMed ID: 20307152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reader (user) beware.
    Malay DS
    J Foot Ankle Surg; 2014; 53(2):129-30. PubMed ID: 24393612
    [No Abstract]   [Full Text] [Related]  

  • 16. The sins of ghostwriting.
    Somberg JC
    Am J Ther; 2008; 15(4):297-8. PubMed ID: 18645328
    [No Abstract]   [Full Text] [Related]  

  • 17. Authorship policy.
    Novack GD
    Am J Ophthalmol; 2009 Jan; 147(1):184; author reply 184-5. PubMed ID: 19100357
    [No Abstract]   [Full Text] [Related]  

  • 18. Comment on: developing good scientific publishing practices: one pharmaceutical company's perspective.
    Norris RA
    Curr Med Res Opin; 2010 Jul; 26(7):1675-6. PubMed ID: 20450261
    [No Abstract]   [Full Text] [Related]  

  • 19. How to ensure our readers' trust: the proper attribution of authors and contributors.
    Liesegang TJ; Albert DM; Schachat AP
    Am J Ophthalmol; 2008 Sep; 146(3):337-40. PubMed ID: 18724976
    [No Abstract]   [Full Text] [Related]  

  • 20. Conflict of interest and special interest groups. The making of a counter culture.
    Fava GA
    Psychother Psychosom; 2001; 70(1):1-5. PubMed ID: 11150932
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.